LON:SBTX SkinBioTherapeutics (SBTX) Share Price, News & Analysis GBX 5.76 +0.01 (+0.17%) As of 12:16 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsNews and Trends About SkinBioTherapeutics Stock (LON:SBTX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get SkinBioTherapeutics alerts:Sign Up Key Stats Today's Range 5.76▼ 6.2550-Day Range 5.20▼ 10.7552-Week Range 5▼ 23Volume87,749 shsAverage Volume2.83 million shsMarket Capitalization£14.93 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis. The company has an agreement with Croda Plc; and operates two research programmes with the University of Manchester, an oral programme and an inflammation study. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom. Read More Receive SBTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SkinBioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SBTX Stock News HeadlinesSkinBioTherapeutics Shifts Registered Office to East Yorkshire in Cost-Focused MoveOctober 15 at 2:11 AM | tipranks.comSkinBioTherapeutics Expects FY2026 Revenue to Rise 20.5% to £4.7 Million as CEO and Chair Appointments ConfirmedSeptember 22, 2026 | uk.finance.yahoo.comTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered. Buried inside is what some call the legal groundwork for the biggest change to American money in over a century, with a key Treasury vote potentially as soon as January 18. Ian King, Chief Strategist at Strategic Fortunes, breaks down what the order could mean for the dollar and the financial system.October 16 at 1:00 AM | Banyan Hill Publishing (Ad)SkinBioTherapeutics Strengthens Finance Team with Interim CFO AppointmentAugust 24, 2026 | uk.finance.yahoo.comSkinBioTherapeutics Stock Price HistoryJuly 28, 2026 | investing.comSkinBioTherapeutics restates FY25 accounts following investigation into former CEO conduct (SBTX)June 8, 2026 | uk.finance.yahoo.comSkinBioTherapeutics Finalises Financial Investigation and Appoints New Auditor Ahead of Results Publication (SBTX)May 28, 2026 | uk.finance.yahoo.comSkinBioTherapeutics shares jump 10% as mystery investor builds 22% stake through company crisisMarch 13, 2026 | uk.finance.yahoo.comSee More Headlines SBTX Stock Analysis - Frequently Asked Questions How have SBTX shares performed this year? SkinBioTherapeutics' stock was trading at GBX 15.77 at the beginning of the year. Since then, SBTX shares have decreased by 63.5% and is now trading at GBX 5.76. How were SkinBioTherapeutics' earnings last quarter? SkinBioTherapeutics plc (LON:SBTX) issued its quarterly earnings data on Monday, June, 8th. The company reported ($0.31) earnings per share (EPS) for the quarter. The firm had revenue of $2.17 million for the quarter. SkinBioTherapeutics had a negative trailing twelve-month return on equity of 5.25% and a negative net margin of 8.73%. How do I buy shares of SkinBioTherapeutics? Shares of SBTX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Company Calendar Last Earnings6/08/2026Today10/16/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolLON:SBTX CIKN/A Webwww.skinbiotherapeutics.com Phone+44-161-4682760FaxN/AEmployees11Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (0.16) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£3.71 million Net Margins-8.73% Pretax MarginN/A Return on Equity-5.25% Return on Assets-61.18% Debt Debt-to-Equity Ratio11.77 Current Ratio6.14 Quick Ratio10.01 Sales & Book Value Annual Sales£5.23 million Price / Sales2.86 Cash FlowGBX 0.64 per share Price / Cash Flow9.00 Book ValueGBX 1.68 per share Price / Book3.43Miscellaneous Outstanding Shares259,169,000Free FloatN/AMarket Cap£14.93 million OptionableNot Optionable Beta0.10 Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (LON:SBTX) was last updated on 10/16/2026 by MarketBeat.com Staff. From Our PartnersElon Musk’s 4th Wealth Window Set to Open by October 30Jeff Brown, the analyst who flagged Bitcoin, Tesla, and Nvidia early, is tracking Elon Musk's next move. He po...Brownstone Research | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and ...Porter & Company | SponsoredSpaceX minted 4400 millionaires in a single daySpaceX minted 4,400 millionaires in a single day, and Tesla has turned more than 5,000 employees into milliona...Behind the Markets | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredUndiscovered Sub-$1 Gold-Silver Royalty Stock Takes FlightA small-cap gold and silver royalty company is generating record revenue from producing mines, yet shares stil...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SkinBioTherapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share SkinBioTherapeutics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
